KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Gains from Investment Securities (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Gains from Investment Securities readings, the most recent being $316000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 170.09% to $316000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $483000.0, a 108.65% increase, with the full-year FY2025 number at $354000.0, up 165.8% from a year prior.
  • Gains from Investment Securities hit $316000.0 in Q4 2025 for Ginkgo Bioworks Holdings, up from $167000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $18.5 million in Q3 2021 to a low of -$5.3 million in Q4 2023.
  • Median Gains from Investment Securities over the past 5 years was $316000.0 (2025), compared with a mean of $1.1 million.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 348.89% in 2022 and later plummeted 391.93% in 2024.
  • Ginkgo Bioworks Holdings' Gains from Investment Securities stood at $1.1 million in 2021, then skyrocketed by 348.89% to $5.0 million in 2022, then plummeted by 205.2% to -$5.3 million in 2023, then soared by 102.21% to $117000.0 in 2024, then surged by 170.09% to $316000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $316000.0 (Q4 2025), $167000.0 (Q1 2025), and $117000.0 (Q4 2024) per Business Quant data.